Aceclofenac Paracetamol And Serratiopeptidase Tablets

₹ 1,200/Box

CompositionAceclofenac 100mg + Paracetamol 325mg + Serratiopeptidase 15mg
Packaging Size10*10 Tablets
Packaging TypeBox
BrandFensia-SP
ManufacturerAvosia
Shelf Life24 Months
UsagePain Relief from headache and musculoskeletal pain
Prescription/Non-PrescriptionPrescription
Also GivesPCD Pharma Franchise
Medicine TypeAllopathic
ApplicationClinic, Hospital
FormTablets
TreatmentReduction of pain and inflammation due to bone or soft tissue injury, resolution of postoperative
Country of OriginMade in India
AvailabilityIn Stock
Avosia Pharma introduces Fensia-SP Tablets, a powerful triple-action combination of Aceclofenac, Paracetamol, and Serratiopeptidase, formulated to deliver fast and effective relief from pain, inflammation, and swelling. Ideal for orthopedic, post-surgical, and dental use, Fensia-SP offers broad-spectrum anti-inflammatory support with enhanced healing action.

Find products similar to Aceclofenac Paracetamol And Serratiopeptidase Tablets

Find related categories

Shipping Information

PriceExcluding all taxes
Ships fromPanchkula
ShippingAs per delivery location

Product Image

Aceclofenac Paracetamol And Serratiopeptidase Tablets image 1Aceclofenac Paracetamol And Serratiopeptidase Tablets image 2Aceclofenac Paracetamol And Serratiopeptidase Tablets image 3

About the Company

GST Registration Date
May 2023
Legal Status of Firm
Limited Company
Nature of Business
Trader - Retailer
Number of Employees
11 To 25 People
Annual Turnover
1.5 - 5 Cr
IndiaMART Member Since
May 2023
GST
06**********1ZF

Established in the year of 2023, We “Avosia Pharma Private Limited” are Wholesale Trader and Manufacturer of an Pharmaceutical Tablets, etc. We direct all our activities to cater the expectations of customers by providing them excellent quality products as per their gratification. Moreover, we follow moral business policies and crystal pure transparency in all our transactions to keep healthy relations with the customers.

For our accomplishment story, whose continual backing and direction have been useful to us for attaining exponential development in the current market.